Alpha Teknova (NASDAQ:TKNO – Get Free Report) is expected to release its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of ($0.0833) per share and revenue of $10.9610 million for the quarter. Individuals can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 6:00 PM ET.
Alpha Teknova (NASDAQ:TKNO – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.01. Alpha Teknova had a negative net margin of 41.07% and a negative return on equity of 24.32%. The company had revenue of $11.08 million for the quarter, compared to analyst estimates of $10.23 million.
Alpha Teknova Stock Up 6.0%
Shares of TKNO opened at $5.30 on Tuesday. The firm has a market cap of $284.13 million, a P/E ratio of -16.56 and a beta of 0.64. Alpha Teknova has a 12 month low of $1.91 and a 12 month high of $6.68. The stock’s 50 day moving average is $5.11 and its two-hundred day moving average is $3.69. The company has a current ratio of 4.59, a quick ratio of 3.60 and a debt-to-equity ratio of 0.20.
Analyst Ratings Changes
Institutional Investors Weigh In On Alpha Teknova
A number of large investors have recently made changes to their positions in TKNO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Alpha Teknova during the 2nd quarter worth $29,000. JPMorgan Chase & Co. grew its holdings in shares of Alpha Teknova by 123.1% in the second quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock valued at $40,000 after purchasing an additional 4,504 shares during the period. Larson Financial Group LLC increased its position in Alpha Teknova by 58.5% during the third quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock worth $58,000 after purchasing an additional 3,464 shares during the last quarter. XTX Topco Ltd acquired a new stake in Alpha Teknova during the fourth quarter worth about $77,000. Finally, Sherbrooke Park Advisers LLC purchased a new position in Alpha Teknova during the third quarter worth about $94,000. 13.81% of the stock is currently owned by hedge funds and other institutional investors.
Alpha Teknova Company Profile
Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.
The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.
Featured Stories
- Five stocks we like better than Alpha Teknova
- Tether Strikes Gold: Crypto’s Physical Pivot
- Jersey Mike’s Serves Fresh Gains After IPO Stumble
- 3 Drone Stocks That Should Soar After the Summer Slump
- Tyson Foods Offers a Meaty Opportunity for Income Investors
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
